Inhibitors | Comment | Organism | Structure |
---|---|---|---|
CT peptide | a PC2-specific inhibitor | Rattus norvegicus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | - |
Rattus norvegicus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
64000 | - |
x * 75000, pro-PC2 form, SDS-PAGE, x * 64000, mature PC2 form, SDS-PAGE | Rattus norvegicus |
75000 | - |
x * 75000, pro-PC2 form, SDS-PAGE, x * 64000, mature PC2 form, SDS-PAGE | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | healthy and ischemic | Rattus norvegicus | - |
cell culture | - |
Rattus norvegicus | - |
cerebral cortex | high PC2 protein content at early ischeic reperfusion hour, which decreases with reperfusion time | Rattus norvegicus | - |
neuronal cell | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
dynorphin-A(1-8) + H2O | - |
Rattus norvegicus | ? | - |
? | |
L-pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O | - |
Rattus norvegicus | L-pGlu-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 75000, pro-PC2 form, SDS-PAGE, x * 64000, mature PC2 form, SDS-PAGE | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
PC2 | - |
Rattus norvegicus |
proprotein convertase 2 | - |
Rattus norvegicus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5 | - |
assay at | Rattus norvegicus |
Organism | Comment | Expression |
---|---|---|
Rattus norvegicus | transient upregulation of the mRNA level for PC2 in cerebral cortex at an early reperfusion h in a cerebral ischemia model in rats | up |
General Information | Comment | Organism |
---|---|---|
malfunction | PC2 activity is reduced in ischemic brains, brain ischemia attenuates PC2 and PC2-mediated neuropeptide processing. This attenuation may play a role in the pathology of ischemic brain injury. Intracerebroventricular administration of synthetic PC2 substrate dynorphin-A(1-8) significantly reduces the extent of ischemic brain injury, overview | Rattus norvegicus |
physiological function | PC2 mediates neuropeptide processing in the brain | Rattus norvegicus |